Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Person › Details

Jan van de Winkel (Genmab A/S (CSE: GEN, Nasdaq: GMAB))

van de Winkel, Jan (Genmab 201106 CEO before CSO + Co-Founder before Medarex Europe)

 

Organisations Organisation Genmab A/S (CSE: GEN, Nasdaq: GMAB)
  Group Genmab (Group)
  Former/major organisation Medarex Europe B.V.
  Group Bristol Myers Squibb (BMS) (Group)
Products Product DuoBody technology platform (bispecific antibodies)
  Product 2 Arzerra®
     

   
Record changed: 2023-04-17

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px


More documents for Jan van de Winkel


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px




» top